Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Your comments will be sent to our moderator for review.
By submitting your information you agree to our Privacy and Cookie Policy.

Report comment to moderator

Required fields.

Headline

School run ban may be anti-obesity step too far

Comment

A new FDA approved diet pill called Belviq just went on the market. People who take Belviq with diet and exercise were 2 times more likely to lose 5% body weight and 3 times more likely to lose 10% body weight than the people who just did diet and exercise alone. The label states that if you do not lose 5% of your body weight in 12 weeks then consider stopping. Those that do respond in 12 weeks go on to lose over 10% of their body weight in one year. Losing 22 pounds for a 220 pound man is life changing. So comments about average weight loss are misleading and incorrect since over 45% of the patients lost a significant amount of weight. Belviq makes you more likely to succeed because it helps you feel full more quickly, reduces cravings, and helps control "food issues". It is not a 'magic pill', it merely helps people willing to diet and exercise more likely to succeed. Belviq has a second mode of action to reduce blood sugar which may end up preventing diabetes in many cases. Diabetics and pre-diabetics who took Belviq, regardless of weight loss, saw their blood sugar numbers drop by double digit percentages. IE HbA1c -0.9 to -1.2 and fasting glucose feel -27. The cost of medications to reduce HbA1c levels exceeds the cost of Belviq. (seeArena's BloomDM phase III trial) These reductions in diabetic symptoms plus the weight loss at the same time makes Belviq a medical bargain. With an estimated 40 million new cases of Diabetes expected over the next 10 years at a cost of over $400 billion per year to the US Health Care System, and the associated heart disease, strokes, blindness and amputations, any tool that will prevent this preventable disease from ballooning is a good tool to have. People who are borderline diabetic may benefit a great deal from Belviq whether they lose a lot of weight or just a little.

Posted date

5 July, 2013

Posted time

4:00 am

required
required
required
required